GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the apo form of the glutaminyl-tRNA synthetase catalytic domain from toxoplasma gondii.

Analyse Crystal structure of the apo form of the glutaminyl-tRNA synthetase catalytic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4P2B
Type
protein
Length
507 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glutamine aminoacyl-tRNA synthetase
UniProt
D3XAP9
Ligands
SO4
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlutamine aminoacyl-tRNA synthetaseprotein50730% helix, 24% strandD3XAP9

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11120.680.9026empty
25370.670.7864empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 4P2B · Crystal structure of the apo form of the glutaminyl-tRNA synthetase catalytic domain from… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.